Jag Capital Management LLC decreased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 23.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 42,880 shares of the biotechnology company's stock after selling 13,206 shares during the quarter. Axon Enterprise accounts for 3.6% of Jag Capital Management LLC's portfolio, making the stock its 6th largest position. Jag Capital Management LLC owned about 0.06% of Axon Enterprise worth $25,484,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Prestige Wealth Management Group LLC grew its position in Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company's stock worth $33,000 after purchasing an additional 44 shares during the period. New Wave Wealth Advisors LLC purchased a new position in shares of Axon Enterprise in the 4th quarter worth $40,000. Brooklyn Investment Group bought a new stake in shares of Axon Enterprise in the third quarter worth $41,000. Y.D. More Investments Ltd purchased a new stake in shares of Axon Enterprise during the 4th quarter valued at about $45,000. Finally, Planning Capital Management Corp raised its position in Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company's stock worth $48,000 after acquiring an additional 55 shares during the period. Institutional investors own 79.08% of the company's stock.
Analyst Upgrades and Downgrades
AXON has been the subject of several analyst reports. Robert W. Baird increased their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a report on Friday, December 6th. Barclays set a $726.00 price objective on shares of Axon Enterprise and gave the stock an "overweight" rating in a research note on Thursday, February 27th. JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Craig Hallum downgraded shares of Axon Enterprise from a "buy" rating to a "hold" rating and set a $625.00 target price for the company. in a report on Thursday, February 20th. Finally, TD Cowen assumed coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a "buy" rating and a $700.00 price target on the stock. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $587.38.
Get Our Latest Report on AXON
Insiders Place Their Bets
In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares of the company's stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Michael Garnreiter sold 1,000 shares of the company's stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $639.69, for a total transaction of $639,690.00. Following the transaction, the director now owns 24,259 shares in the company, valued at $15,518,239.71. The trade was a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 5,146 shares of company stock valued at $3,262,847 over the last ninety days. 6.10% of the stock is owned by insiders.
Axon Enterprise Price Performance
AXON traded up $27.09 during trading hours on Friday, hitting $526.40. The company's stock had a trading volume of 1,277,703 shares, compared to its average volume of 853,402. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The business's 50-day moving average price is $601.11 and its 200-day moving average price is $527.38. The stock has a market cap of $40.14 billion, a price-to-earnings ratio of 136.02, a P/E/G ratio of 5.17 and a beta of 1.12.
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.